Skip to main content
. 2016 May 6;9:2725–2733. doi: 10.2147/OTT.S75104

Table 2.

Skin toxicity

Vemurafenib Dabrafenib
Rash: 49% Hyperkeratosis: 39%
Photosensitivity: 31% Photosensitivity: rare
SCC: 19% SCC: 10%
Alopecia: 26% Alopecia: rare
Others (pruritus, dry skin, papillomas): frequent Others (pruritus, dry skin, papillomas): not frequent

Abbreviation: SCC, squamous cell carcinoma including keratoacanthoma.